Kiromic Biopharma Correlations

KRBPDelisted Stock  USD 2.68  0.07  2.55%   
The current 90-days correlation between Kiromic Biopharma and Quoin Pharmaceuticals Ltd is -0.03 (i.e., Good diversification). The correlation of Kiromic Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Kiromic Biopharma Correlation With Market

Good diversification

The correlation between Kiromic Biopharma and DJI is -0.04 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Kiromic Biopharma and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Moving together with Kiromic Stock

  0.66VALN Valneva SE ADRPairCorr
  0.69VCNX VaccinexPairCorr
  0.66DRMA Dermata TherapeuticsPairCorr
  0.71DTIL Precision BioSciencesPairCorr
  0.79VINC Vincerx PharmaPairCorr
  0.68VRCA Verrica PharmaceuticalsPairCorr

Moving against Kiromic Stock

  0.67DRUG Bright Minds BiosciencesPairCorr
  0.67SABSW SAB BiotherapeuticsPairCorr
  0.63VCYT VeracytePairCorr
  0.48VERA Vera TherapeuticsPairCorr
  0.46DMAC DiaMedica TherapeuticsPairCorr
  0.46VAXX VaxxinityPairCorr
  0.8VRNA Verona Pharma PLCPairCorr
  0.72VSTM VerastemPairCorr
  0.55VRDN Viridian TherapeuticsPairCorr
  0.32KTTAW Pasithea TherapeuticsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
VRAXALLR
CYTOALLR
BDRXALLR
BDRXVRAX
IMMXVRAX
CYTOBDRX
  
High negative correlations   
IMMXZURA
ZURAALLR
ZURAVRAX
CYTOZURA
CNSPZURA
ZURABDRX

Risk-Adjusted Indicators

There is a big difference between Kiromic Stock performing well and Kiromic Biopharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Kiromic Biopharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
QNRX  6.20  0.25  0.04  0.29  6.71 
 17.65 
 74.46 
ALLR  5.02 (1.99) 0.00 (1.81) 0.00 
 10.85 
 41.48 
VRAX  5.89 (1.00) 0.00  2.77  0.00 
 9.65 
 61.28 
BDRX  6.55 (1.61) 0.00 (0.41) 0.00 
 11.91 
 97.78 
ZURA  3.89 (0.50) 0.00 (0.15) 0.00 
 7.95 
 30.69 
CYTO  3.50 (1.17) 0.00  58.15  0.00 
 6.98 
 22.81 
IMMX  3.87 (0.35) 0.00 (0.14) 0.00 
 7.06 
 32.68 
ENVB  3.22 (0.65) 0.00 (2.30) 0.00 
 6.25 
 28.33 
PALI  3.52 (0.37) 0.00  0.55  0.00 
 5.97 
 24.25 
CNSP  4.99 (0.47) 0.00 (0.17) 0.00 
 9.09 
 39.29 

View Kiromic Biopharma Related Equities

 Risk & Return  Correlation

Kiromic Biopharma Corporate Management

Michael RyanChief OfficerProfile
Leonardo MirandolaChief OfficerProfile
JD CPACEO DirectorProfile
Daniel ClarkChief OfficerProfile
MD PharmDChief StaffProfile

Still Interested in Kiromic Biopharma?

Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.